Rapid Immunohistochemistry, Multiplex IF and Digital Pathology Workflow


Rapid immunohistochemistry using Fast Fluidic Technology (FFeX) enables precise and efficient advanced staining techniques, including monoplex and multiplex immunohistochemistry (IHC) and immunofluorescence (IF). Scanning by 3DHistech™ digital pathology solutions enables pathologists to evaluate and collaborate rapidly remotely and with transparency and consistency, thus improving the pathology workflow. Together, the LabSat® Research and Pannoramic Midi II demonstrate a rapid IHC and digital scanning solution. 


Methods for IHC, IF, and multiplexing that deliver high quality stain results and maintain tissue morphology are important for effective tissue research. For example, IHC and IF have been identified as reliable methods that contribute to the study of the tumor microenvironment (TME) (Taube, et al 2020). In addition, technologies that offer high staining quality and morphology while improving workflow efficiencies may further enable the research of important biomarkers. This study highlights rapid IHC and multiplexing IF coupled with efficient and high quality scanning through 3DHistech systems.


Read the full article now

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Translational Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Webinar
Tired of Manual Staining? Meet the LabSat® Research Platform

| Sponsored by Epredia

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts